Lpl Financial LLC Rubius Therapeutics, Inc. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.14 - $0.31 $2,378 - $5,266	-16,990 Reduced 30.18%	39,307 $7,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $1.29 $3,470 - $9,731	-7,544 Reduced 11.82%	56,297 $24,000
Q2 2022 Aug 12, 2022	BUY	$0.79 - $5.98 $10,814 - $81,860	13,689 Added 27.3%	63,841 $54,000
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $91,043 - $222,788	21,422 Added 74.56%	50,152 $276,000
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $4,965 - $9,100	513 Added 1.82%	28,730 $278,000
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $134,252 - $197,641	-7,628 Reduced 21.28%	28,217 $505,000
Q2 2021 Aug 13, 2021	SELL	$22.26 - $28.43 $185,425 - $236,821	-8,330 Reduced 18.86%	35,845 $875,000
Q1 2021 May 14, 2021	SELL	$8.02 - $32.01 $19,448 - $77,624	-2,425 Reduced 5.2%	44,175 $1.17 Million
Q4 2020 Feb 12, 2021	BUY	$4.23 - $8.73 $25,380 - $52,380	6,000 Added 14.78%	46,600 $354,000
Q3 2020 Nov 09, 2020	BUY	$4.65 - $6.25 $25,551 - $34,343	5,495 Added 15.65%	40,600 $203,000
Q2 2020 Aug 13, 2020	BUY	$4.01 - $6.88 $12,936 - $22,194	3,226 Added 10.12%	35,105 $210,000
Q1 2020 May 14, 2020	BUY	$3.74 - $9.84 $37,224 - $97,937	9,953 Added 45.39%	31,879 $142,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $31,530 - $61,577	4,361 Added 24.83%	21,926 $208,000
Q3 2019 Nov 13, 2019	BUY	$7.85 - $15.75 $54,714 - $109,777	6,970 Added 65.79%	17,565 $138,000
Q2 2019 Aug 09, 2019	SELL	$13.5 - $19.94 $36,720 - $54,236	-2,720 Reduced 20.43%	10,595 $167,000
Q1 2019 May 08, 2019	BUY	$13.27 - $18.51 $42,729 - $59,602	3,220 Added 31.9%	13,315 $241,000
Q4 2018 Feb 07, 2019	BUY	$13.83 - $22.97 $139,613 - $231,882	10,095 New	10,095 $162,000

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account